刀马旦
1-7月社会消费商品和服务零售总额同比增长2.6%_我的网站
A |
A Chinese research team has identified a new potential target to develop antidepressant drug from Qingyangshen, or Root of Auricledleaf Swallowwort, a traditional ethnic medicinal plant long used in Southwest China's Yunnan Province, according to Kunming University of Science and Technology, Science and Technology Daily reported Sunday.
The team, led by professors Xu Tianrui and Xiang Cheng from the university's School of Life Science and Technology, found that Qingyangshen glycosides, the plant's core active compound, can alleviate depression-related behaviors by simultaneously suppressing inflammation, reducing oxidative damage and stabilizing neurotransmitters in the brain.
The findings were published in the international journal Phytomedicine.
Depression has become a widespread mental health disorder globally, while existing clinical drugs fail to provide effective treatment for more than 30 percent of patients, according to the researchers. Previous studies have established a strong link between chronic inflammation and depression, but existing anti-inflammatory drugs have limited targeting capabilities, underscoring the need for new therapeutic targets and lead compounds.
Qingyangshen, a plant of the Cynanchum genus in the Apocynaceae family, has long been used as a traditional medicine by ethnic groups including the Naxi, Yi and Bai peoples in Yunnan, mainly for treating neurological conditions such as epilepsy and neurasthenia.
The researchers systematically examined the pharmacological effects of Qingyangshen extract and its core active compound, Qingyangshen glycosides. Tests using mouse, zebrafish and fruit fly models repeatedly showed that the compound significantly improved depression-related behaviors induced by inflammation, according to the report.
To identify the compound's target, the team developed a dual-discrimination model for four subtypes of prostaglandin E2 receptors and combined it with AI-powered machine learning. The researchers screened hundreds of G protein-coupled receptors and identified the prostaglandin E2 subtype 4 receptor as the direct target of Qingyangshen glycosides.
Multiple molecular experiments confirmed that the compound binds directly to the receptor and acts as an inhibitory ligand. Further experiments involving animals with the receptor knocked out in the hippocampus showed that the antidepressant effects of Qingyangshen glycosides disappeared completely when the receptor was absent, providing the first in-vivo evidence that the receptor is essential for the compound's therapeutic effects.
The study establishes the prostaglandin E2 subtype 4 receptor as a potential new target for antidepressant drug development and points to a new approach to treating depression through inflammatory pathways. It also identifies Qingyangshen glycosides as a potential lead compound for developing highly targeted anti-inflammatory antidepressants, creating a research chain from ethnic medicinal plants and active compounds to drug targets and new drug development.
Global Times
。 讯 据商务部8月20日消息，商务部消费促进司负责人谈2026年7月我国消费市场情况。 今年以来，我国消费市场保持向新向优发展态势，市场规模稳步扩大、发展质量不断提升。1-7月，社会消费商品和服务零售总额同比（下同）增长2.6%；社会消费品零售总额28.77万亿元，增长1.2%，其中除汽车以外的消费品零售额增长2.7%。 一是商品消费提质升级。7月份，商品零售额增长0.5%。基本生活类商品增长平稳，限额以上单位粮油食品、饮料、日用品零售额分别增长5.3%、3.5%、1.8%；部分升级类商品增长较快，限额以上单位通讯器材、文化办公用品、化妆品零售分别增长20.4%、7.4%、6.8%。 二是服务消费亮点纷呈。暑期服务消费潜力充分释放。1-7月，服务零售额增长5.0%，持续高于商品零售额增速。其中，餐饮收入增长2.6%；旅游咨询租赁服务、文体休闲服务零售额增长超过10%。暑期档电影火热，7月份电影总票房超50亿元，增长超过20%。
B | 三是新型消费蓬勃发展。消费品以旧换新带动绿色、智能消费增长。7月份，新能源乘用车零售渗透率65.1%，再创历史新高。商务部商务大数据显示，7月份重点平台具身智能机器人销售额增长95.1%，外骨骼助力器销售额增长39.5%，运动相机销售额增长24.7%，扫地机器人销售额增长19.4%。 四是城乡结构持续优化。1-7月，乡村消费品零售额3.8万亿元，增长2.4%，增速比城镇快1.3个百分点。县域消费市场动能不断加强，包含镇区和乡村的县乡消费品零售额占社会消费品零售总额的比重达39.1%，比上年同期提高0.3个百分点。版权申明：凡注有“”或电头为“”的稿件，均为独家版权所有，未经许可不得转载或镜像；授权转载必须注明来源为“”，并保留“”的电头。 。
Current article:http://iwfv.suiyangguiduanzudoushaopao.buzz/news/20260826_4878963.html
Published on:17:29:42